INTRODUCTION AND OBJECTIVES: MicroRNAs regulate diverse biological processes. Previously we identified miRNA-regulated pathways in bladder outlet obstruction (BOO)-induced bladder dysfunction. MiRNAs in a cluster reside in genomic proximity (<10 kb) and their expression might be mediated by common transcription factors. Here we probed functional associations of BOO phenotype-specific miRNAs and identified several co-expressed miRNA sub-networks.
INTRODUCTION AND OBJECTIVES: The spinal serotonin (5HT) system is well known to be involved in the control of lower urinary tract function, and we previously reported that 5HT receptors such as 5HT 1A or 5HT 2C , have respectively inhibit or enhance the urethral continence reflex during sneezing in rats. However, because there are multiple 5HT receptor subtypes, it is often difficult to determine the subtype-specific mechanism. Thus, we examined the role of 5HT 7 receptors in the urethral continence mechanism using a rat model of stress urinary incontinence (SUI), in which endogenous 5HT was depleted by p-chlorophenylalanine (PCPA).
METHODS: Female Sprague-Dawley rats were used. PCPA (200 mg/kg/day) was administered intraperitoneally for two days. Thereafter, using a microtransducer-tipped catheter inserted to the midurethra, we assessed urethral baseline pressure (UBP), amplitudes of urethral responses during sneezing (AURS) and abdominal pressure during sneezing (Pabd) under urethane anesthesia before and after administration of following drugs. First, we investigated the effects of a 5HT 7 and partial 5HT 1A agonist (LP 44 ¼ LP, 0.3mg/kg, iv) in PCPAadministered rats. To suppress the partial 5HT 1A effect of LP, a 5HT 1A antagonist (WAY 100635 ¼ WAY, 0.1 mg/kg, iv) was administered before LP treatment. Secondly, we investigated whether the effects of LP in the presence of WAY were inhibited by a 5HT 7 antagonist (SB 269970 ¼ SB, 0.1 mg/kg, iv), which was administered with WAY prior to LP administration. All data are shown in cmH 2 O. RESULTS: After LP administration (n ¼ 6), UBP and AURS were significantly increased compared to the PCPA + WAY (n ¼ 4) or PCPA only group (n ¼ 7) (UBP: 15.2 vs 16.8 vs 26.6, AURS: 30.0 vs 32.2 vs 50.5 [PCPA only vs PCPA + WAY vs PCPA + WAY + LP], respectively) ( Figure) . However, in the presence of the SB, UBP and AURS were not significantly increased after LP administration (n ¼ 6) compared to the PCPA + WAY (n ¼ 6) or PCPA only group (n ¼ 6). Pabd had no statistical difference among groups.
CONCLUSIONS: The 5HT 7 receptor exerts the facilitatory effects on the urethral baseline activity and the urethral continence reflex during stress conditions such as sneezing, which are reportedly attributable to contractions of smooth and striated urethral sphincter muscles, respectively. Thus, 5HT 7 agonists could be effective for the treatment of SUI.
